Study on infection and wound healing after vulvar surgery
Part of Women’s health & pregnancy clinical trials.
This study looks at whether having an infection before surgery affects healing after removal of non-cancerous vulvar growths. It may help decide if treating infections first could lower complication rates.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- You have a non-cancerous growth on your vulva that needs to be removed.
- You are scheduled or planning to have a wide local excision or skinning vulvectomy.
- You are not pregnant or breastfeeding.
- You have not had radiation therapy to the pelvic area.
- You have not taken antibiotics in the last 3 weeks.
- You have not had cancer in the last 3 years that required chemotherapy or radiation.
- You are not taking medications that weaken the immune system (except inhaled steroids).
- You do not have uncontrolled diabetes.
- You do not have active HIV (viral load must be undetectable).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at two tumor test results—HPV and p53—to help doctors decide how much tissue to remove during surgery for vulvar squamous cell carcinoma. It’s meant to reduce the risk of the cancer coming back while avoiding unnecessary removal when margins are only close.
This study looks at whether different post-surgery wound-care steps can reduce problems at the incision site after elective ventral hernia repair. If you qualify, you may receive a specific wound treatment plan chosen by the study team to see how it affects healing and infection rates.
This trial tests giving chemotherapy (carboplatin and paclitaxel) before surgery for certain cases of squamous cell vulvar cancer. It may help shrink the tumor and make surgery more effective.
This trial is for people with early-stage vulvar cancer that can be surgically removed. It looks at the cancer's HPV and p53 status to decide how much tissue to remove, aiming to reduce side effects while keeping the cancer away.
This study is building a database (a secure record) to learn about vaginal/vulva conditions in women. You may be invited if you’re coming in for a routine women’s health visit or you’re being seen for a vaginal concern, and you can share information safely.
This Phase 2 study looks at how vulvar squamous cell cancer (SCC) spreads to the sentinel lymph node, and how findings may guide treatment. It focuses on specific early-stage tumor features and requires that cancer is found in the sentinel lymph node.
Hear when a new Vaginitis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.